Search Results - "Lai, Timothy Y. Y."

Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial by Koh, Adrian, Lai, Timothy Y Y, Takahashi, Kanji, Wong, Tien Y, Chen, Lee-Jen, Ruamviboonsuk, Paisan, Tan, Colin S, Feller, Chrystel, Margaron, Philippe, Lim, Tock H, Lee, Won Ki

“…Polypoidal choroidal vasculopathy (PCV) is a common subtype of exudative age-related macular degeneration among Asian individuals. To our knowledge, there are…”
Get more information

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial by Lim, Tock H, Lai, Timothy Y Y, Takahashi, Kanji, Wong, Tien Y, Chen, Lee-Jen, Ruamviboonsuk, Paisan, Tan, Colin S, Lee, Won Ki, Cheung, Chui Ming Gemmy, Ngah, Nor Fariza, Patalauskaite, Ramune, Margaron, Philippe, Koh, Adrian

“…The 2-year efficacy and safety of combination therapy of ranibizumab administered together with verteporfin photodynamic therapy (vPDT) compared with…”
Get more information

Insights Into the Global Epidemic of High Myopia and Its Implications by Ng, Danny S C, Lai, Timothy Y Y

Get more information

Pachychoroid: current concepts on clinical features and pathogenesis by Castro-Navarro, Veronica, Behar-Cohen, Francine, Chang, Woohyok, Joussen, Antonia M., Lai, Timothy Y. Y., Navarro, Rafael, Pearce, Ian, Yanagi, Yasuo, Okada, Annabelle A.

“…Purpose The term “pachychoroid” refers to a newly described phenotype in which functional and structural choroidal changes are thought to play a key pathogenic…”
Get full text

Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy by Marmor, Michael F., MD, Kellner, Ulrich, MD, Lai, Timothy Y.Y., MD, Lyons, Jonathan S., MD, Mieler, William F., MD

“…Background The American Academy of Ophthalmology recommendations for screening of chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy were published in…”
Get full text

Assessment of Parafoveal Diabetic Macular Ischemia on Optical Coherence Tomography Angiography Images to Predict Diabetic Retinal Disease Progression and Visual Acuity Deterioration by Yang, Dawei, Tang, Ziqi, Ran, Anran, Nguyen, Truong X, Szeto, Simon, Chan, Jason, Wong, Cherie Y K, Hui, Vivian, Tsang, Ken, Chan, Carmen K M, Tham, Clement C, Sivaprasad, Sobha, Lai, Timothy Y Y, Cheung, Carol Y

“…The presence of diabetic macular ischemia (DMI) on optical coherence tomography angiography (OCTA) images predicts diabetic retinal disease progression and…”
Get more information

Myopic choroidal neovascularisation: current concepts and update on clinical management by Wong, Tien Y, Ohno-Matsui, Kyoko, Leveziel, Nicolas, Holz, Frank G, Lai, Timothy Y, Yu, Hyeong Gon, Lanzetta, Paolo, Chen, Youxin, Tufail, Adnan

“…Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia and pathological myopia. Despite significant advances in understanding…”
Get more information

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study by Hamilton, Robin D, Clemens, Andreas, Minnella, Angelo Maria, Lai, Timothy Y Y, Dai, Hong, Sakamoto, Taiji, Gemmy Cheung, Chui Ming, Ngah, Nor Fariza, Dunger-Baldauf, Cornelia, Holz, Frank G

“…To assess the 1-year effectiveness, safety, and treatment patterns of ranibizumab in patients with myopic choroidal neovascularization (mCNV) enrolled in the…”
Get full text

Ocular imaging at the cutting-edge by Lai, Timothy Y. Y.

Get full text

Evolving treatment paradigms for PCV by Fenner, Beau J., Cheung, Chui Ming Gemmy, Sim, Shaun S., Lee, Won Ki, Staurenghi, Giovanni, Lai, Timothy Y. Y., Ruamviboonsuk, Paisan, Kokame, Gregg, Yanagi, Yasuo, Teo, Kelvin Y. C.

“…Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular AMD (nAMD) that accounts for a significant proportion of nAMD cases worldwide, and…”
Get full text

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials by Takahashi, Kanji, Cheung, Chui Ming Gemmy, Iida, Tomohiro, Lai, Timothy Y. Y., Ohji, Masahito, Yanagi, Yasuo, Kawano, Mika, Ohsawa, Shino, Suzuki, Tomoyuki, Kotecha, Aachal, Lin, Hugh, Patel, Vaibhavi, Swaminathan, Balakumar, Lee, Won Ki

“…Purpose To evaluate 1-year efficacy, durability, and safety of faricimab among patients from Asian countries in the TENAYA/LUCERNE trials of neovascular…”
Get full text

Choroidal neovascularization in pathological myopia by Neelam, Kumari, Cheung, Chiu Ming Gemmy, Ohno-Matsui, Kyoko, Lai, Timothy Y.Y., Wong, Tien Y.

“…Myopic choroidal neovascularization (CNV) is one of the leading causes of visual impairment worldwide. The clinical and socioeconomic impact of myopic CNV in…”
Get full text

Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous Chorioretinopathy : One-Year Results of a Randomized Controlled Trial by CHAN, Wai-Man, LAI, Timothy Y. Y, LAI, Ricky Y. K, LIU, David T. L, LAM, Dennis S. C

“…To evaluate the efficacy of photodynamic therapy (PDT) with half-dose verteporfin for treating acute central serous chorioretinopathy (CSC). Prospective,…”
Get full text

The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients by Cheung, Chui Ming Gemmy, Yang, Elizabeth, Lee, Won Ki, Lee, Gary K. Y., Mathur, Ranjana, Cheng, Jacob, Wong, Doric, Wong, Tien Yin, Lai, Timothy Y. Y.

“…Purpose We aimed to evaluate the long-term natural history of polypoidal choroidal vasculopathy (PCV) in untreated patients. Methods This is a retrospective…”
Get full text

LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY by Tan, Nikolle W, Ohno-Matsui, Kyoko, Koh, Hyoung J, Nagai, Yoshimi, Pedros, Montse, Freitas, Rita L, Macfadden, Wayne, Lai, Timothy Y

“…To evaluate long-term efficacy and safety of ranibizumab for treatment of myopic choroidal neovascularization (mCNV) in clinical practice. Noninterventional,…”
Get full text

Impact of the LEAVO Study in Asia by Zhang, Xinyuan, Lai, Timothy Y. Y.

Get full text

Surgical treatment for diabetic vitreoretinal diseases: a review by Sharma, Tarun, Fong, Angie, Lai, Timothy Y, Lee, Vincent, Das, Sudipta, Lam, Dennis

“…Over the past four decades, advancements in surgical instrumentations and techniques have significantly improved the postoperative anatomical and visual…”
Get full text

The potential of spectral domain optical coherence tomography imaging based retinal biomarkers by Phadikar, Prateep, Saxena, Sandeep, Ruia, Surabhi, Lai, Timothy Y Y, Meyer, Carsten H, Eliott, Dean

“…Biomarker", a merged word of "biological marker", refers to a broad subcategory of medical signs that objectively indicate the state of health, and well-being…”
Get full text

A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis by Tang, Fangyao, Wang, Xi, Ran, An-Ran, Chan, Carmen K M, Ho, Mary, Yip, Wilson, Young, Alvin L, Lok, Jerry, Szeto, Simon, Chan, Jason, Yip, Fanny, Wong, Raymond, Tang, Ziqi, Yang, Dawei, Ng, Danny S, Chen, Li Jia, Brelén, Marten, Chu, Victor, Li, Kenneth, Lai, Tracy H T, Tan, Gavin S, Ting, Daniel S W, Huang, Haifan, Chen, Haoyu, Ma, Jacey Hongjie, Tang, Shibo, Leng, Theodore, Kakavand, Schahrouz, Mannil, Suria S, Chang, Robert T, Liew, Gerald, Gopinath, Bamini, Lai, Timothy Y Y, Pang, Chi Pui, Scanlon, Peter H, Wong, Tien Yin, Tham, Clement C, Chen, Hao, Heng, Pheng-Ann, Cheung, Carol Y

“…Diabetic macular edema (DME) is the primary cause of vision loss among individuals with diabetes mellitus (DM). We developed, validated, and tested a deep…”
Get full text

Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization : Six-Month Results of a Prospective Pilot Study by CHAN, Wai-Man, LAI, Timothy Y. Y, LIU, David T. L, LAM, Dennis S. C

“…To evaluate the safety and efficacy of intravitreal bevacizumab in the treatment of choroidal neovascularization (CNV) secondary to pathologic myopia (PM)…”
Get full text